CNBC
US · 2 hrs ago
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
—Quality
0Ratings
0Comments
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!